Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1973-05-29
1976-03-30
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 250303, G01N 3300, G01T 116
Patent
active
039475646
ABSTRACT:
A method for determining serum thyroxine (T-4) in which the T-4 is first separated from the serum by adsorption onto a montmorillonite clay and then competitively bound by exogenous thyroxine binding globulin in the presence of a known amount of radioactive T-4. The competitively bound serum T-4 and radioactive T-4 is separated from the unbound serum T-4 and radioactive T-4 by passage through an ion exchange resin column. The serum T-4 concentration is determined by measuring the amount of bound radioactive T-4 and referring to a standard curve.
REFERENCES:
patent: 3414383 (1968-12-01), Murphy
patent: 3451777 (1965-08-01), DiGiulio
patent: 3555001 (1971-01-01), Wallis et al.
patent: 3659104 (1972-04-01), Gross et al.
patent: 3666854 (1972-05-01), Eisentraut
patent: 3714344 (1973-01-01), Brown
patent: 3776698 (1973-12-01), Eisentraut
Dahlstrom Robert V.
Shannon Charles F.
Bio-Rad Laboratories
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Radioactive determination of serum thyroxine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioactive determination of serum thyroxine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioactive determination of serum thyroxine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-521694